ICN Biomedicals Inc.: The Costa Mesa biotechnology...
- Share via
ICN Biomedicals Inc.: The Costa Mesa biotechnology research products and medical diagnostics company posted first-quarter profit of $514,000, or 6 cents a share, down from $1 million, or 5 cents a share, reported for the 1993 first quarter. Sales declined to $15.5 million from $15.8 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
